Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect

Min Gao(Bristol-Myers Squibb (United States)), Richard E. Nettles(Bristol-Myers Squibb (United States)), Makonen Belema, Lawrence B. Snyder, Van N. Nguyen, Robert A. Fridell(Bristol-Myers Squibb (United States)), Michael H. Serrano‐Wu, David R. Langley(Institute for Computer Aided Design), Jin-Hua Sun(Bristol-Myers Squibb (United States)), Donald R. O’Boyle(Bristol-Myers Squibb (United States)), Julie A. Lemm(Bristol-Myers Squibb (United States)), Chunfu Wang(Bristol-Myers Squibb (United States)), Jay O. Knipe(Bristol-Myers Squibb (United States)), Caly Chien(Bristol-Myers Squibb (United States)), Richard J. Colonno(Bristol-Myers Squibb (United States)), Dennis M. Grasela(Bristol-Myers Squibb (United States)), Nicholas A. Meanwell, Lawrence G. Hamann
Nature
April 21, 2010
10.1038/nature08960
Cited by 937Open Access
Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis